Chinks in the armor of the airway: Pseudomonas infection in the cystic fibrosis lung

American Journal of Respiratory Cell and Molecular Biology

Volumn 25, Issue 1, 2001, Pages 11-13

  Ferkol, T W ^a   Look, D C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS;

EID: 0034914106     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.25.1.f212     Document Type: Short Survey

References (34)

1. The changing epidemiology of cystic fibrosis
2. Quantitative evaluation of the development of tracheal submucosal glands in infants with cystic fibrosis and control infants
3. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis
4. Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects
5. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator
6. Heterologous expression of ΔF508 CFTR results in decreased sialylation of membrane glycoconjugates
7. Pseudomonas aeruginosa pill bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells
8. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8
9. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence Ga1NAcβ1-4Gal found in some glycolipids
10. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections
11. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung
12. Role of cystic fibrosis transmembrane conductance regulator in pulmonary clearance of Pseudomonas aeruginosa in vivo
13. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation
14. Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosis
15. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
16. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa
17. High susceptibility for cystic fibrosis human airway gland cells to produce IL-8 through the IκB kinase α pathway in response to extracellular NaCl content
18. Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines
19. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis
20. Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase
21. Proteins of the cystic fibrosis respiratory tract - Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis
22. Neutrophil elastase cleaves C3bi on opsonized Pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch
23. Amiloride inhalation therapy in cystic fibrosis - Influence on ion content, hydration, and rheology of sputum
24. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects
25. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease
26. Mucociliary transport in trachea of patients with cystic fibrosis
27. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid
28. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis
29. Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung
30. Activity of abundant antimicrobials of the human airway
31. Osmotic water permeabilities of cultured, well-differentiated normal and cystic fibrosis airway epithelia
32. Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid
33. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA